Laura Cassin

Analista de Capital Privado en

Nimbus Synergies, Inc.

Consumer Services

Finance

Perfil

Laura Cassin is an Investment Analyst at Nimbus Synergies, Inc. since 2017.
She completed her undergraduate degree from the University of Victoria in 1998.

Cargos activos de Laura Cassin

Empresas	Cargo	Inicio
Nimbus Synergies, Inc. Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies invests in companies located in North America primarily in Canada and opportunistically in the United States with revenues of USD 0.5 - 2 million. The firm focuses on the health technology sector. It participates in pre-seed, seed and early stage capital requirements with an investment size of USD 0.25 - 5 million. The firm makes co-investments and also acts as a lead investor. It takes a seat on the board of directors. The firm makes follow-on investments and it does not invest in therapeutics and class III devices.	Analista de Capital Privado	01/06/2017

Todos los cargos activos de Laura Cassin

Formación de Laura Cassin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Laura Cassin.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
University of Victoria University of Victoria Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nimbus Synergies, Inc. Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies invests in companies located in North America primarily in Canada and opportunistically in the United States with revenues of USD 0.5 - 2 million. The firm focuses on the health technology sector. It participates in pre-seed, seed and early stage capital requirements with an investment size of USD 0.25 - 5 million. The firm makes co-investments and also acts as a lead investor. It takes a seat on the board of directors. The firm makes follow-on investments and it does not invest in therapeutics and class III devices.	Finance

Empresas privadas